الصفحة الرئيسية>>Signaling Pathways>> GPCR/G protein>> Prostaglandin Receptor>>BAY 73-1449

BAY 73-1449

رقم الكتالوجGC61581

BAY 73-1449 هو مضاد انتقائي لمستقبلات البروستاسكلين (IP) ، ذو فاعلية عالية (IC أقل من 0.1 نانومتر) في فحوصات cAMP في خلايا HEL البشرية و DRG الفئران

Products are for research use only. Not for human use. We do not sell to patients.

BAY 73-1449 التركيب الكيميائي

Cas No.: 693790-96-4

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
248٫00
متوفر
1mg
103٫00
متوفر
5mg
225٫00
متوفر
10mg
338٫00
متوفر
25mg
540٫00
متوفر
50mg
747٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

BAY 73-1449 is a selective antagonist of prostacyclin receptor (IP), with high potency (IC50 of less than 0.1 nM) in cAMP assays in Human HEL cells and rat DRG. BAY 73-1449 can be used in the research of lowering blood pressure[1].

BAY 73-1449 (0.1-1 mg/kg; i.v.) does not significantly reduce mesenteric inflow, but significantly reduces splenic shunt vessel outflow in rats[1].BAY 73-1449 (1-5 mg/kg, s.c. once daily for 7 d) has no effects on the degree of porto-systemic shunting in rats[1].BAY 73-1449 (1 mg/kg, s.c. once daily for 7 d), has no effects on portal pressures in rats[1]. Animal Model: Male Wistar rats (250-350 g) are ligated portal vein[1]

[1]. Bexis S, et, al. Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat. Eur J Pharmacol. 2008 Aug 20;590(1-3):322-6.

مراجعات

Review for BAY 73-1449

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for BAY 73-1449

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.